World Medical Biosensors Market Review by Infiniti Research Recently Updated at

27 Mar 2012 • by Natalie Aster

LONDON – The wider use of glucose detection methods and devices due to rising awareness about diabetes, as well as the increased use of medical biosensors in home diagnostics and in research oriented hospitals and laboratories, is leading to strong growth of the global medical biosensors market, which, in turn, is becoming more commercially viable in the industry, with its various advanced range of technologically adopted products. However, this market growth could be challenged by the rapid obsolescence of devices.

Updated report “Global Medical Biosensors Market 2010-2014” worked out by Infiniti Research provides a comprehensive review of the medical biosensors market from a global perspective. It features current market trends, key growth drivers and restraints, profiles of top global market participants, as well as projections for the market for the years 2010 through 2014.

Key vendors discussed in the report include: Universal Biosensors Inc., Nova Biomedical Corp., Abbott Laboratories, Bayer AG, and Lifescan Inc.

Report Details:

Global Medical Biosensors Market 2010-2014
Published: February, 2012
Pages: 30
Price: US$ 1.500,00

More updated and new market reports by the publisher can be found at Infiniti Research page.


MarketPublishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970